US EPA INHALATION REFERENCE CONCENTRATION FOR BROMOMETHANE

Citation
Dj. Guth et Am. Jarabek, US EPA INHALATION REFERENCE CONCENTRATION FOR BROMOMETHANE, Inhalation toxicology, 6, 1994, pp. 327-339
Citations number
14
Categorie Soggetti
Toxicology
Journal title
ISSN journal
08958378
Volume
6
Year of publication
1994
Supplement
S
Pages
327 - 339
Database
ISI
SICI code
0895-8378(1994)6:<327:UEIRCF>2.0.ZU;2-I
Abstract
The EPA inhalation reference concentration (RfC) for bromomethane was derived based on lesions observed in rat nasal epithelium from a chron ic study. Reuzel et al. (1991) exposed Wistar rats to 0, 3, 30, or 90 ppm bromomethane for 6 h/day, 5 days/wk for up to 29 mo. Hyperplastic changes in the basal cells accompanied by degeneration in the olfactor y epithelium in the dorso-medial part of the nasal cavity were observe d in all exposed groups of both sexes at 29 mo of exposure. These chan ges were concentration-related in both incidence and severity and were statistically significant at 29 mo. The effect was not statistically significant in smaller groups of animals examined after 12 or 24 mo of exposure. This study identifies a lowest-observed-adverse-effect leve l (LOAEL) at 3 ppm in the rat. In the chronic National Toxicology Prog ram (NTP) study (NTP, 1992), B6C3F1 mice were exposed to 0, 10, 33, or 100 ppm bromomethane for 6 h/day, 5 days/wk, for either 6, 15, or 24 mo. A statistically significant increase in the incidence of olfactory epithelial necrosis and metaplasia was seen in the nasal cavities of male and female mice exposed to 100 ppm. Mice exposed to lower concent rations did not exhibit significant increases in any of the lesions. B ased on the results of this study, a LOAEL of 100 ppm and a no-observe d-adverse-effect level (NOAEL) of 33 ppm was identified in mice. The R fC was based on the more sensitive effect from the rat study. The appa rent 30-fold difference in the effect level between the 24- and 29-mo durations is surprising, because comparison of the effects after expos ures ranging from I day to 24 mo shows similar effect levels. The LOAE L of 3 mg/m(3) was adjusted to a continuous exposure scenario [LOAEL(A DJ) = 2.08 mg/mg3], and the human equivalent concentration was calcula ted to be 0.48 mg/m3. This value was divided by an uncertainty factor of 100, which includes intraspecies uncertainty, use of a LOAEL for a mild effect, and interspecies extrapolation. The resulting RfC is 5 mu g/m(3).